Refractory Ileal Perforations in a Cytomegalovirus-Infected Premature Neonate Resolved After Ganciclovir Therapy

Severe neonatal gastrointestinal diseases such as necrotizing enterocolitis or spontaneous intestinal perforation is a potentially lethal condition that predominantly occurs in premature babies. Cytomegalovirus (CMV), which is known to cause congenital and acquired infections in newborns, has also been implicated in gastrointestinal diseases such as severe in premature infants. However, the pathogenic role of CMV and the effects of antiviral therapy in severe gastrointestinal illness in premature neonates is currently unclear.

We present the baby, born at 26-weeks gestation, presented with progressive dyspepsia and abdominal distention after closure of patent ductus arteriosus symptoms on the day of life (DOL) 4, which requires emergency surgery for ileal perforation in DOL8 it. After surgery, abdominal symptoms persist and operation appeared both performed for recurrent ileal perforation in DOL17. Even after prolonged abdominal symptoms and pathological examination in the affected bowel in a second operation showed CMV inclusion bodies.

Immunoreactivity for CMV antigen was detected in specimens from the first operation on DOL8. Blood and urine CMV-DNA were detected in DOL28. CMV-DNA was also detected in umbilical cord dry obtained within a week of birth. A 6-week course of intravenous ganciclovir (12 mg / kg / day) was started in DOL34 and then the symptoms resolved together with a reduction in CMV-DNA blood. Pathologic findings characteristic of CMV was not detected in the resection specimen in DOL94 ileostomy closure.

These observations suggest that the anti-CMV therapy may be beneficial for some preterm infants with severe gastrointestinal disease related CMV and warrants further research focusing on the role of pathogens, diagnosis, treatment and prevention of this underrecognized etiology severe gastrointestinal disease, especially in premature neonates.

 Refractory Ileal Perforations in a Cytomegalovirus-Infected Premature Neonate Resolved After Ganciclovir Therapy
Refractory Ileal Perforations in a Cytomegalovirus-Infected Premature Neonate Resolved After Ganciclovir Therapy

Primary Human Cytomegalovirus Infection and Reactivation: Insights From Molecules Virion-Carried

Human cytomegalovirus (HCMV), a ubiquitous beta-herpes virus, are able to build life-long latency after initial infection. periodic reactivation occurred after immunosuppression, remains a major cause of death in immunocompromised patients. HCMV have to achieve structural balance and functional with the host at the beginning of the entry. virion-do mediators considered to play an important role in the adaptation of the virus into new cellular environment at the time of entry.

Moreover, a clear distinction between primary infection and reactivation is the idea that the virion-packaged factor has been formed so that the molecule can be used quickly by the virus. Instead, the mediator virion-do should be transcribed and translated; thus, they are not available for reactivation. Therefore, understanding the molecular virion-do help to explain HCMV reactivation. In this article, the impact of molecules on the virion-packaged virus structure, biological behavior and life cycle of the virus will be reviewed.

NATtrol Cytomegalovirus (CMV) Strain: AD-169 (100,000 cp/mL) (1 mL)

NATCMV-0005 100,000 cp/mL , 1mL
EUR 908.64
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Cytomegalovirus (CMV) Strain: AD-169 External Run Control, Low (6X1 mL)

NATCMV-ERCL 6X1 mL
EUR 406.94
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Cytomegalovirus (CMV) Strain: AD-169 Linearity Panel (6 X 0.25 mL)

NATCMV-LIN 6 X 0.25 mL
EUR 635.33
Description: Please contact Gentaur in order to receive the datasheet of the product.

NATtrol Cytomegalovirus (CMV) Strain:AD-169 External Run Control, Medium (6X1mL)

NATCMV-ERCM 6X1mL
EUR 481.82
Description: Please contact Gentaur in order to receive the datasheet of the product.

Hepatitis Surface Antigen subtype Ad (HBsAg Ad), Native (human plasma) purified

HBA26-N-100 100 ug
EUR 270

Human Adropin (AD) ELISA Kit

DLR-AD-Hu-48T 48T
EUR 664.8
Description: A sandwich quantitative ELISA assay kit for detection of Human Adropin (AD) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Adropin (AD) ELISA Kit

DLR-AD-Hu-96T 96T
EUR 870
Description: A sandwich quantitative ELISA assay kit for detection of Human Adropin (AD) in samples from serum, plasma, tissue homogenates or other biological fluids.

Human Adropin (AD) ELISA Kit

RD-AD-Hu-48Tests 48 Tests
EUR 675.6

Human Adropin (AD) ELISA Kit

RD-AD-Hu-96Tests 96 Tests
EUR 939.6

Human Adropin (AD) ELISA Kit

RDR-AD-Hu-48Tests 48 Tests
EUR 706.8

Human Adropin (AD) ELISA Kit

RDR-AD-Hu-96Tests 96 Tests
EUR 984

Rat IgG2b Isotype Control Purified

11-169-C100 0.1 mg
EUR 163.2

Virus Cytomegalovirus (CMV) Protein

abx670257-1ml 1 ml
EUR 493.2

Cytomegalovirus Antibody / CMV / PP65

V2332-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2332SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop Cytomegalovirus infections. In some patients with AIDS, the virus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of the disease. An indicator of active infection is needed to facilitate the diagnosis of cytomgalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus was detected in the leukocytes of both the peripheral blood and BALF during the early phase of the disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333-20UG 20 ug
EUR 219
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Cytomegalovirus Antibody / CMV / PP65

V2333SAF-100UG 100 ug
EUR 499
Description: Ten to forty percent of the patients with acquired immunodeficiency syndrome (AIDS) develop cytomegalovirus (CMV) infections. In some patients with AIDS, cytomegalovirus is detected in the bronchoalveolar lavage fluid (BALF), urine, and other specimens, even when there are no symptoms of cytomegalovirus disease. An indicator of active CMV infection is needed to facilitate the diagnosis of cytomegalovirus disease in patients with AIDS or HIV infection. Cytomegalovirus p65 antigen was detected in the leukocytes of both the peripheral blood and BALF during the early phase of CMV disease.

Sucrose

abx082163-500g 500 g
EUR 210

Sucrose

abx082558-500g 500 g
EUR 226.8

Sucrose

GC4473-100G 100 g
EUR 45.6

Sucrose

GC4473-10KG 10 kg
EUR 217.2

Sucrose

GC4473-1KG 1 kg
EUR 64.8

Sucrose

GC4473-250G 250 g
EUR 48

Sucrose

GC4473-2KG 2 kg
EUR 87.6

Sucrose

GC4473-500G 500 g
EUR 52.8

Sucrose

GC4473-5KG 5 kg
EUR 141.6

Sucrose

HY-B1779 10mM/1mL
EUR 135.6

SUCROSE

S19-117-10kg 10 kg
EUR 648

SUCROSE

S19-117-2kg 2kg
EUR 188.4

SUCROSE

S19-117-500g 500 g
EUR 94.8

Sucrose

SB0498 500g
EUR 71.45

Sucrose

TB01275 8XX100mg
EUR 328.8

Cytomegalovirus (CMV) Chimeric 1 Protein

abx061513-1mg 1 mg
EUR 1796.4

Cytomegalovirus gH (CMV gH) Antibody

abx415688-01mg 0.1 mg
EUR 777.6

Cytomegalovirus (CMV) IgG ELISA Kit

K4150-100 each
EUR 646.8

Cytomegalovirus (CMV) IgM ELISA Kit

K4151-100 each
EUR 646.8

Cyanine 7 bisacid [equivalent to Cy7® bisacid]

169 5 mg
EUR 262.8

Recombinant (Pichia Pastoris) Hepatitis Surface Antigen (HBsAg, Ad/Ay), purified

HBA35-N-500 0.5 mg
EUR 416.4

Recombinant (Yeast) purified Hepatitis B surface Antigen (HBsAg, Ad/Ay)

HBSAG19-R-1 1 mg
EUR 1220.4

AD 0261

HY-U00005 10mg
EUR 4440

pGADT7- AD

PVT4018 2 ug
EUR 319.2

Sucrose (saccharose)

16-0020-1000 1 kg
EUR 111.6

Iron sucrose

GC0709-100G 100 g
EUR 228

Iron sucrose

GC0709-25G 25 g
EUR 103.2

Iron sucrose

GC0709-50G 50 g
EUR 146.4

Sucrose stearate

GC2889-25G 25 g
EUR 98.4

Sucrose stearate

GC2889-5G 5 g
EUR 54

Sucrose benzoate

GC4185-1KG 1 kg
EUR 170.4

Sucrose benzoate

GC4185-500G 500 g
EUR 112.8

Sucrose octaacetate

GC6190-1KG 1 kg
EUR 146.4

Sucrose octaacetate

GC6190-250G 250 g
EUR 70.8

Sucrose octaacetate

GC6190-500G 500 g
EUR 98.4

Recombinant Cytomegalovirus (CMV), Pp150 (UL32), (AD169 Strain) (32 kDa), GST-tagged

DAG499 1mg
EUR 1648.8

CMV (Cytomegalovirus Antibody IgM) ELISA test

29 96T/Box Ask for price
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgM)

CMV (Cytomegalovirus Antibody IgG) ELISA test

28 96T/Box Ask for price
Description: ELISA based test for quantitative detection of CMV (Cytomegalovirus Antibody IgG)

Virus Cytomegalovirus Antigen (CMV-Ag) Protein

abx670278-1mg 1 mg
EUR 1045.2

Cytomegalovirus Early Antigen (CMV-EA) Antibody

abx411287-02mg 0.2 mg
EUR 678

CMV control lentivirus (Hygro)

CMV-Null-Hygro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the hygromycin selection under RSV promoter.

CMV control lentivirus (Zeo)

CMV-Null-Zeo 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It has the Zeocin selection under RSV promoter.

CMV Control lentiviral particles (Bsd)

CMV-Null-Bsd 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the blasticidin marker under RSV promoter.

CMV Control lentiviral particles (Neo)

CMV-Null-Neo 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Neomycin marker under RSV promoter.

CMV Control lentiviral particles (Puro)

CMV-Null-Puro 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the Puromycin marker under RSV promoter.

Cytomegalovirus Immediate Early Antigen (CMV-IE) Antibody

abx415689-01mg 0.1 mg
EUR 760.8

Recombinant Cytomegalovirus gB (C194 Strain) (32kDa), GST-tagged

DAG495 1mg
EUR 1674

Adropin (AD) Antibody

20-abx171122
  • EUR 1111.20
  • EUR 560.40
  • 1 mg
  • 200 ug

HBsAg ad Protein

abx060555-100ug 100 ug
EUR 1053.6

Mouse AD Protein

20-abx650992
  • EUR 944.40
  • EUR 360.00
  • EUR 2983.20
  • EUR 1128.00
  • EUR 661.20
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Adropin (AD) Antibody

20-abx175288
  • EUR 1612.80
  • EUR 760.80
  • 1 mg
  • 200 ug

Recombinant Adropin (AD)

4-RPN251Hu01
  • EUR 657.60
  • EUR 300.00
  • EUR 2136.00
  • EUR 792.00
  • EUR 1464.00
  • EUR 516.00
  • EUR 5160.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Adropin expressed in: E.coli

Recombinant Adropin (AD)

4-RPN251Mu01
  • EUR 679.10
  • EUR 304.80
  • EUR 2216.64
  • EUR 818.88
  • EUR 1517.76
  • EUR 530.40
  • EUR 5361.60
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Adropin expressed in: E.coli

Valrubicin (AD-32)

B1833-25 each
EUR 895.2

Valrubicin (AD-32)

B1833-5 each
EUR 268.8

Sucrose Assay Kit

55R-1468 100 assays
EUR 826.8
Description: Assay Kit for detection of Sucrose in the research laboratory

Dodecanoyl-D-sucrose

GC7623-250MG 250 mg
EUR 122.4

3,6-Disinapoyl sucrose

TB0776 20mg
EUR 320.4

CMV Control lentiviral particles (GFP-Bsd)

CMV-Null-GB 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Blasticidin fusion marker under RSV promoter.

CMV Control lentiviral particles (GFP-Puro)

CMV-Null-GP 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the GFP-Puromycin fusion marker under RSV promoter.

CMV Control lentiviral particles (RFP-Bsd)

CMV-Null-RB 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Blasticidin fusion marker under RSV promoter.

CMV Control lentiviral particles (RFP-Puro)

CMV-Null-RP 1 x107 IFU/ml x 200ul
EUR 418.8
Description: Negative control lentivirus contains a null spacer insert under CMV promoter, serves as the negative control of lentivurs treatment for the specificity of any target expression effects. It also has the RFP-Puromycin fusion marker under RSV promoter.

Cytomegalovirus pp65 Antibody

abx021650-1mg 1 mg
EUR 1387.2

Cytomegalovirus gB Protein

20-abx260105
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Recombinant Cytomegalovirus Pp38

DAG531 1mg
EUR 1537.2

Anti-Cytomegalovirus antibody

STJ16100359 1 mL
EUR 1120.8

CPI-169

B4678-10 10 mg
EUR 324
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-100 100 mg
EUR 1730.4
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-5 5 mg
EUR 247.2
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-5.1 10 mM (in 1mL DMSO)
EUR 626.4
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

CPI-169

B4678-50 50 mg
EUR 1027.2
Description: CPI-169 is a novel, small molecule and potent inhibitor of enhancer of zeste homolog 2 (EZH2) with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2) [1].CPI-169 has been found to be a potent EZH2 inhibitor with an IC50 value of <1nM for polycomb repressive complex 2 (PRC2).

SD 169

C5850-10 10 mg
EUR 141.6
Description: SD 169 (indole-5-carboxamide) is a selective and ATP competitive inhibitor of the MAP kinases p38? and p38? [1].

SD 169

C5850-25 25 mg
EUR 252
Description: SD 169 (indole-5-carboxamide) is a selective and ATP competitive inhibitor of the MAP kinases p38? and p38? [1].

CPI-169

HY-15956A 5mg
EUR 639.6

Cytomegalovirus Late Matrix Antigen (CMV-LA Matrix) Antibody

abx411280-1ml 1 ml
EUR 610.8

Cytomegalovirus Late Nuclear Antigen (CMV-LA Nuclear) Antibody

abx411286-02mg 0.2 mg
EUR 678

Human anti-cytomegalovirus(CMV) antibody (IgG) ELISA Kit

CSB-E09063h-24T 1 plate of 24 wells
EUR 198
Description: Qualitative indirect ELISA kit for measuring Human anti-cytomegalovirus (CMV) antibody (IgG) in samples from serum. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human anti-cytomegalovirus(CMV) antibody (IgG) ELISA Kit

1-CSB-E09063h
  • EUR 600.00
  • EUR 4082.40
  • EUR 2184.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Qualitative indirect ELISA kit for measuring Human anti-cytomegalovirus(CMV) antibody (IgG) in samples from serum. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human anti-cytomegalovirus(CMV) antibody (IgM) ELISA Kit

CSB-E09546h-24T 1 plate of 24 wells
EUR 198
Description: Qualitative captureELISA ELISA kit for measuring Human anti-cytomegalovirus (CMV) antibody (IgM) in samples from serum, plasma. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price.

Human anti-cytomegalovirus(CMV) antibody (IgM) ELISA Kit

1-CSB-E09546h
  • EUR 600.00
  • EUR 4082.40
  • EUR 2184.00
  • 1 plate of 96 wells
  • 10 plates of 96 wells each
  • 5 plates of 96 wells each
Description: Qualitative captureELISA ELISA kit for measuring Human anti-cytomegalovirus(CMV) antibody (IgM) in samples from serum, plasma. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits.

Human Cytomegalovirus (CMV) IgG ELISA Kit (Direct EIA)

EK7032 96wells/kit, with removable strips.
EUR 573.6

Human Cytomegalovirus (CMV) IgM ELISA Kit (Direct EIA)

EK7033 96wells/kit, with removable strips.
EUR 573.6

ELISA kit for Human Cytomegalovirus Antigen (CMV Ag)

KTE62775-48T 48T
EUR 424.8
Description: Quantitative sandwich ELISA for measuring Human Cytomegalovirus Antigen (CMV Ag) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Cytomegalovirus Antigen (CMV Ag)

KTE62775-5platesof96wells 5 plates of 96 wells
EUR 2702.4
Description: Quantitative sandwich ELISA for measuring Human Cytomegalovirus Antigen (CMV Ag) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

ELISA kit for Human Cytomegalovirus Antigen (CMV Ag)

KTE62775-96T 96T
EUR 686.4
Description: Quantitative sandwich ELISA for measuring Human Cytomegalovirus Antigen (CMV Ag) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids.

Human anti-cytomegalovirus IgG ,anti-CMV ELISA Kit

YLA4265HU-48T 48T
EUR 435

Human anti-cytomegalovirus IgG ,anti-CMV ELISA Kit

YLA4265HU-96T 96T
EUR 562.5

Recombinant Cytomegalovirus Antigen, Pp65 (UL83), Strain AD169, GST-tagged

DAG524 1mg
EUR 1648.8

Virus Hepatitis B Virus Surface Antigen ad (HBsAg ad) Protein

abx670255-01mg 0.1 mg
EUR 844.8

HBsAg protein (subtype ad)

30-1815 500 ug
EUR 522
Description: Native Human HBsAg protein (Subtype ad)

HBsAg protein (Subtype ad)

30-AH15 1 mg
EUR 417.6
Description: Purified native Human HBsAg protein (Subtype ad)

Sucrose Synthase (SUS1) Antibody

20-abx319796
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Sucrose (Plant) Assay Kit

abx298802-100Assays 100 Assays
EUR 566.4

Sucrose Synthase Assay Kit

abx298804-100Assays 100 Assays
EUR 679.2

3, 6?-Disinapoyl Sucrose

N2096-20 20 mg
EUR 602.4
Description: Extracted from Polygala tenuifolia Willd. dried roots;Store the product in sealed, cool and dry condition

Sucrose octasulfate sodium salt

GK4916-1G 1 g
EUR 265.2

Sucrose octasulfate sodium salt

GK4916-250MG 250 mg
EUR 122.4

Poly(sucrose-co-epichlorhydrin)

GM4452-100G 100 g
EUR 409.2

EnzyChrom Sucrose Assay Kit

ESUC-100 100
EUR 499.2
Description: Quantitative determination of sucrose by colorimetric (565nm) method. Procedure: 70 min. Kit size: 100 tests. Detection limit: 17 µM. Shelf life: 3 months. Shipping: on ice; storage: -20°C.

Sucrose octasulfate-aluminum complex

GC0234-10G 10 g
EUR 274.8

Sucrose octasulfate-aluminum complex

GC0234-1G 1 g
EUR 84

Sucrose octasulfate-aluminum complex

GC0234-5G 5 g
EUR 180

Sucrose octasulfate potassium salt

GC1775-1G 1 g
EUR 180

PHENOL RED SUCROSE BROTH

P16-123-10kg 10 kg
EUR 1002

PHENOL RED SUCROSE BROTH

P16-123-2Kg 2 Kg
EUR 265.2

PHENOL RED SUCROSE BROTH

P16-123-500g 500 g
EUR 115.2

Calibration Fluid Sucrose 60%

SS60 EACH
EUR 79.8

0 % Sucrose in Water

BS00 15ML
EUR 85.5

Sucrose Standard Stabilised 15ML

BS60S 15ML
EUR 78.66

Hepatitis B Virus Surface Antigen ad/ay (HBsAg ad/ay) Antibody

abx411401-1ml 1 ml
EUR 610.8

Hepatitis B Virus Surface Antigen ad/ay (HBsAg ad/ay) Antibody

abx411404-02mg 0.2 mg
EUR 678

Recombinant Cytomegalovirus Pp28 (UL99) (AD169 Strain), (30 kDa), GST-tagged

DAG496 1mg
EUR 1537.2

Cytomegalovirus gB Recombinant Protein

53-303 0.01 mg
EUR 789.9
Description: Cytomegalovirus gB Recombinant Protein

Cytomegalovirus p28 Recombinant Protein

53-304 0.01 mg
EUR 789.9
Description: Cytomegalovirus p28 Recombinant Protein

Cytomegalovirus p150 Recombinant Protein

53-305 0.01 mg
EUR 789.9
Description: Cytomegalovirus p150 Recombinant Protein

Cytomegalovirus UL83 Recombinant Protein

53-306 0.01 mg
EUR 852.9
Description: Cytomegalovirus UL83 Recombinant Protein

Cytomegalovirus Pp28 (UL99) Protein

20-abx260106
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Cytomegalovirus Pp38 (UL80a) Protein

20-abx260107
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Cytomegalovirus Pp52 (UL44) Protein

20-abx260108
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Cytomegalovirus Pp65 (UL83) Protein

20-abx260109
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Cytomegalovirus Pp150 (UL32) Protein

20-abx260110
  • EUR 1062.00
  • EUR 410.40
  • EUR 1646.40
  • 0.5 mg
  • 100 ug
  • 1 mg

Cytomegalovirus Glycoprotein Recombinant Protein

97-053 0.05 mg
EUR 714.3
Description: Human cytomegalovirus is a species of the Cytomegalovirus genus of viruses, which in turn is a member of the viral family known as Herpesviridae or herpesviruses. It is typically abbreviated as HCMV or, commonly but more ambiguously, as CMV. CMV Virus Envelope Glycoportein B (CMV-GB) can be cleaved into glycoprotein GP55. Envelope glycoprotein that plays a role in host cell entry, cell to-cell virus transmission, and fusion of infected cells. CMV-GB may be involved in the initial attachment via binding to heparan sulfate together with the gM/gN complex that binds heparin with higher affinity. Furthermore, CMV-GB can interact with host integrin ITGB1, PDGFRA and EGFR that likely serve as postattachment entry receptors. Also, CMV-GB participates in the fusion of viral and cellular membranes leading to virus entry into the host cell. Membrane fusion is mediated by the fusion machinery composed at least of gB and the heterodimer gH/gL.

Cytomegalovirus UL83 recombinant antigen

8817 100 ug
EUR 673.36
Description: This is Cytomegalovirus UL83 recombinant antigen for ELISA,WB.

Mouse antibody for Cytomegalovirus

887 100 ug
EUR 431.93
Description: This is Mouse monoclonal FITC conjugated antibody against Cytomegalovirus pp65 for WB, ELISA.

Cytomegalovirus gB recombinant antigen

8965 100 ug
EUR 608.1
Description: This is Cytomegalovirus gB recombinant antigen for ELISA,WB.

Cytomegalovirus p28 recombinant antigen

8966 100 ug
EUR 608.1
Description: This is Cytomegalovirus p28 recombinant antigen for ELISA,WB.

Cytomegalovirus p150 recombinant antigen

8967 100 ug
EUR 608.1
Description: This is Cytomegalovirus p150 recombinant antigen for ELISA,WB.

Cytomegalovirus IgG ELISA Kit

DEIA013 96T
EUR 858
Description: The CMV IgG ELISA is intended for use in the detection of Cytomegalovirus Antibody IgG in human serum.

Cytomegalovirus IgG ELISA Kit

DEIA326 96T
EUR 795.6
Description: Enzyme immunoassay for the quantitative determination of IgG antibodies against Cytomegalovirus in human serum and plasma.

Anti-Human Cytomegalovirus antibody

STJ16100451 1 mL
EUR 1092

Anti-Cytomegalovirus p65 antibody

STJ16101049 100 µg
EUR 424.8

Anti-Cytomegalovirus p65 antibody

STJ16101050 100 µg
EUR 424.8

Anti-Cytomegalovirus p65 antibody

STJ16101051 100 µg
EUR 424.8

Human Cytomegalovirus IgM Antibody (Anti-CMV IgM) ELISA Kit

abx054250-96tests 96 tests
EUR 548.4

Human Cytomegalovirus IgG Antibody (Anti-CMV IgG) ELISA Kit

abx354612-96tests 96 tests
EUR 548.4

Cytomegalovirus Early Nuclear Antigen (CMV-EA Nuclear) Antibody (FITC)

abx411281-01mg 0.1 mg
EUR 610.8

Cytomegalovirus gH Late Neutralizing Antigen (CMV-LA gH) Antibody

abx411285-02mg 0.2 mg
EUR 678

Mouse Anti-Human Cytomegalovirus (CMV) monoclonal antibody, clone JID671

CABT-L2988-100uL500uL 100 uL, 500 uL
EUR 602.4

ELISA kit for Human anti-cytomegalovirus (CMV) antibody ( IgG)

EK0143 96 tests
EUR 723.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human anti-cytomegalovirus (CMV) antibody ( IgG) in samples from serum, plasma, tissue homogenates and other biological fluids.

ELISA kit for Human anti-cytomegalovirus (CMV) antibody ( IgM)

EK0144 96 tests
EUR 723.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human anti-cytomegalovirus (CMV) antibody ( IgM) in samples from serum, plasma, tissue homogenates and other biological fluids.

Recombinant Salmonella sulA Protein (aa 1-169) (strain RKS4594)

VAng-Wyb1215-1mgEcoli 1 mg (E. coli)
EUR 4173.6
Description: Salmonella paratyphi C (strain RKS4594) Cell division inhibitor SulA, recombinant protein.

Recombinant Salmonella sulA Protein (aa 1-169) (strain RKS4594)

VAng-Wyb1215-500gEcoli 500 µg (E. coli)
EUR 2826
Description: Salmonella paratyphi C (strain RKS4594) Cell division inhibitor SulA, recombinant protein.

Recombinant Salmonella sulA Protein (aa 1-169) (strain RKS4594)

VAng-Wyb1215-50gEcoli 50 µg (E. coli)
EUR 1927.2
Description: Salmonella paratyphi C (strain RKS4594) Cell division inhibitor SulA, recombinant protein.

Recombinant Salmonella sulA Protein (aa 1-169) (strain SL254)

VAng-Wyb1216-1mgEcoli 1 mg (E. coli)
EUR 4173.6
Description: Salmonella newport (strain SL254) Cell division inhibitor SulA, recombinant protein.

Recombinant Salmonella sulA Protein (aa 1-169) (strain SL254)

VAng-Wyb1216-500gEcoli 500 µg (E. coli)
EUR 2826
Description: Salmonella newport (strain SL254) Cell division inhibitor SulA, recombinant protein.

Recombinant Salmonella sulA Protein (aa 1-169) (strain SL254)

VAng-Wyb1216-50gEcoli 50 µg (E. coli)
EUR 1927.2
Description: Salmonella newport (strain SL254) Cell division inhibitor SulA, recombinant protein.

CPI-169 racemate

HY-15956 100mg
EUR 1879.2

Hepatitis B Virus Surface Antigen ad/ay (HBsAg ad/ay) Antibody (HRP)

abx411402-1ml 1 ml
EUR 760.8

HBsAg antibody (Subtype ad/ay)

70-HG15 1 mg
EUR 295.2
Description: Affinity purified Goat polyclonal HBsAg antibody (Subtype ad/ay)

HBsAg antibody (Subtype ad/ay)

70-HG15S 1 mg
EUR 295.2
Description: Affinity purified Goat polyclonal HBsAg antibody (Subtype ad/ay)

HBsAg antibody (Subtype ad/ay)

20-HG20 1 ml
EUR 264
Description: Goat polyclonal HBsAg antibody (Subtype ad/ay)

Human amiodarone,AD ELISA Kit

201-12-1893 96 tests
EUR 528
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids.

Human amiodarone,AD ELISA Kit

CN-04509H1 96T
EUR 525.6

Human amiodarone,AD ELISA Kit

CN-04509H2 48T
EUR 346.8

Rat adropin(AD) ELISA kit

E02A1239-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Rat adropin(AD) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.


Cytomegalovirus (CMV) is the most common congenital infection worldwide, and remains a significant cause of neurological deficiencies and sensory deafness in developed countries. Mrs. primary infection, reactivation or reinfection during pregnancy can cause fetal infections and congenital CMV syndrome. The purpose of this study was to analyze the seroprevalence of CMV in accordance with the demographic features of pregnant women in Western Romania as well as the evolution of CMV immunity in two intervals.